Healthcare, Biotech & Pharma
Cigno and our international team, M&A Worldwide, specialize in 12 industry groups. Each Industry Group gathers experienced M&A practitioners with sector-specific areas of expertise from different geographical regions, including Denmark.
This group covers the healthcare, biotechnology and pharmaceutical industries and is always keeping track of its developments, as well as new demands and strategic requirements, enabling us to be a valuable M&A partner.
According to our Worldwide Healthcare, Biotech & Pharma Group, these are the sectors’ trends:
- Players to pursue category leadership
- Investment capital to keep deals flowing in
- Oncology remains popular
- Life-saving drugs more business attractive
Working with us will allow you to benefit from the in-depth and up-to-date knowledge and experience in the healthcare, biotechnology & pharmaceutical sectors.
Novo Nordisk was exclusively advised on the acquisition/merge of 5 sub-contractors
Lindcon Optical Group A/S was sold in MBO
